SEC Form 4 · accession 0001209191-16-133291
Ampio Pharmaceuticals, Inc. · AMPE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory A Gould
Officer — Chief Financial Officer
Period of report
Jul 15, 2016
Accepted (ET)
Jul 19, 2016 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411906
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $1.03 | Jul 15, 2016 | A | 150,000 | A | — | Jul 15, 2026 | Common Stock | 150,000 | 416,666 | D |
Explanation of responses
- F1The Stock Option vests and becomes exercisable in three equal installments. 1/3rd of the shares vested on the grant date July 15, 2016; 1/3rd of the shares shall vest on July 15, 2017; and 1/3rd of the shares shall vest on July 15, 2018.